Luo, Haizhen
Ikenaga, Naoki
Nakata, Kohei
Higashijima, Nobuhiro
Zhong, Pingshan
Kubo, Akihiro
Wu, Chenyi
Tsutsumi, Chikanori
Shimada, Yuki
Hayashi, Masataka
Oyama, Koki
Date, Satomi
Abe, Toshiya
Ideno, Noboru
Iwamoto, Chika
Shindo, Koji
Ohuchida, Kenoki
Oda, Yoshinao
Nakamura, Masafumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP22H02922, JP22J11407, JP22K15560)
GlaxoSmithKline Japan (2021)
Shinnihon Foundation of Advanced Medical Research (Shinnihon Foundation of Advanced Medical Research)
Takeda Science Foundation (Takeda Science Foundation)
JST SPRING (JPMJSP2136)
Article History
Received: 24 May 2024
Accepted: 2 September 2024
First Online: 11 September 2024
Declarations
:
: All patients provided informed consent, and the study adhered to the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Kyushu University (30–230; 858-00). All animal experimental protocols were approved by the Ethics Committee of Kyushu University (A22-128; A22-160; A22-161; A22-339) and performed following the guidelines of the Institutional Animal Committee of Kyushu University.
: Not applicable.
: The authors declare that they have no competing interests.